Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CRHR1 | P34998 | 1/20 | 0.33 |
| ▸ | FLT3 | P36888 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.32 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.32 |
| ▸ | HTT | P42858 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | AKR1C4 | P17516 | 1/20 | 0.31 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.31 |
| ▸ | AKR1C2 | P52895 | 1/20 | 0.31 |
| ▸ | AKR1C1 | Q04828 | 1/20 | 0.31 |
| ▸ | TP53 | P04637 | 1/20 | 0.31 |
| ▸ | PER2 | O15055 | 1/20 | 0.31 |
| ▸ | CRY1 | Q16526 | 1/20 | 0.31 |
| ▸ | CRY2 | Q49AN0 | 1/20 | 0.31 |
| ▸ | ATM | Q13315 | 1/20 | 0.31 |
| ▸ | CNR2 | P34972 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.30 |
| ▸ | RAB9A | P51151 | 1/20 | 0.30 |
| ▸ | PTGER4 | P35408 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13725692 | 0.95 | L3MBTL1 (0.33) | FLT3L3MBTL1NPSR1HTTKDM4E | |
| SCHEMBL13724534 | 0.94 | KDM4E (0.35) | CRHR1FLT3L3MBTL1NPSR1HTT | |
| SCHEMBL13486066 | 0.92 | L3MBTL1 (0.36) | FLT3L3MBTL1NPSR1HTTKDM4E | |
| SCHEMBL13486021 | 0.92 | L3MBTL1 (0.36) | FLT3L3MBTL1NPSR1HTTKDM4E | |
| SCHEMBL13485865 | 0.92 | L3MBTL1 (0.36) | FLT3L3MBTL1NPSR1HTTKDM4E | |
| SCHEMBL13485966 | 0.92 | L3MBTL1 (0.36) | FLT3L3MBTL1NPSR1HTTKDM4E | |
| SCHEMBL13724531 | 0.92 | FLT3 (0.36) | CRHR1FLT3L3MBTL1NPSR1KDM4E | |
| SCHEMBL13725234 | 0.92 | KDM4E (0.39) | L3MBTL1KDM4EPER2CRY1CRY2 | |
| SCHEMBL13724806 | 0.92 | L3MBTL1 (0.36) | CRHR1FLT3L3MBTL1NPSR1HTT | |
| SCHEMBL13485934 | 0.91 | L3MBTL1 (0.34) | CRHR1FLT3L3MBTL1NPSR1HTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8394511-B2 | Compound for forming organic film, and organic light emitting device and flat panel display device including the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2013-03-12 | — | — | US | disclosed |
| US-8394511-B2 | Compound for forming organic film, and organic light emitting device and flat panel display device including the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2013-03-12 | — | — | US | disclosed |
| US-20090200928-A1 | COMPOUND FOR FORMING ORGANIC FILM, AND ORGANIC LIGHT EMITTING DEVICE AND FLAT PANEL DISPLAY DEVICE INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2009-08-13 | — | — | US | disclosed |
| US-20090200928-A1 | COMPOUND FOR FORMING ORGANIC FILM, AND ORGANIC LIGHT EMITTING DEVICE AND FLAT PANEL DISPLAY DEVICE INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2009-08-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090200928-A1 | COMPOUND FOR FORMING ORGANIC FILM, AND ORGANIC LIGHT EMITTING DEVICE AND FLAT PANEL DISPLAY DEVICE INCLUDING THE SAME | SLCO4C1, PORCN, SLC7A5 | CRHR1 4846/4885FLT3 4436/4885L3MBTL1 1723/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.